Edition:
United Kingdom

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

4.35USD
15 Dec 2017
Change (% chg)

$0.09 (+2.11%)
Prev Close
$4.26
Open
$4.28
Day's High
$4.44
Day's Low
$4.19
Volume
2,089,741
Avg. Vol
314,577
52-wk High
$7.88
52-wk Low
$3.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.60 -0.125
Jun '17 1.60 -0.131
Mar '17 1.60 -0.150
FY 2016 Dec '16 1.60 -0.113
Sep '16 1.60 -0.111
Jun '16 1.70 -1.006
Mar '16 1.97 -0.092
FY 2015 Dec '15 1.92 -0.073
Sep '15 1.87 -0.140
Jun '15 0.27 -0.111
Mar '15 0.27 -0.690
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 5 1.59 1.70 1.46 1.72
Quarter Ending Mar-18 4 1.35 1.60 0.75 1.46
Year Ending Dec-17 4 6.32 6.50 6.00 7.99
Year Ending Dec-18 4 5.45 6.40 3.00 8.49
Earnings (per share)
Quarter Ending Dec-17 5 -0.13 -0.12 -0.15 -0.12
Quarter Ending Mar-18 4 -0.13 -0.12 -0.14 -0.15
Year Ending Dec-17 5 -0.54 -0.52 -0.56 -0.44
Year Ending Dec-18 5 -0.58 -0.53 -0.64 -0.51
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta 1.54 0.85 0.88
Price to Sales (TTM) 139.32 100.68 5.40
Price to Book (MRQ) -- 13.50 5.38
Price to Tangible Book (MRQ) 12.72 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 54.51 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -5.89 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago -14.29 75.04 5.38
Sales - 5 Yr. Growth Rate 59.39 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.01 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago 61.51 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -13.77 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 7.83 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.93 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -762.28 -- --
EBITD - 5 Yr. Avg -3,432.75 -261.13 15.24
Operating Margin (TTM) -767.01 -556.69 7.76
Operating Margin - 5 Yr. Avg. -3,450.43 -279.31 10.75
Pre-Tax Margin (TTM) -789.28 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -3,320.66 -279.05 11.17
Net Profit Margin (TTM) -789.28 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -3,320.66 -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 177,472 25,316,769 864,680,848
Net Income/Employee (TTM) -1,400,750 3,332,346 101,718,394
Receivable Turnover (TTM) 216.58 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.05 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.58 -0.77 11.00
Return on Assets - 5 Yr. Avg. -101.96 -0.26 12.43
Return on Investment (TTM) -45.27 2.36 14.46
Return on Investment - 5 Yr. Avg. -120.26 2.98 16.28
Return on Equity (TTM) -- 2.96 16.05
Return on Equity - 5 Yr. Avg. -220.88 6.41 17.51
  1 Year 3 Year 5 Year
Sales % 58.38 104.69 59.39
EPS (TTM) % -38.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ZIOPHARM Oncology Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 49.58%
# of Holders: 176
Total Shares Held: 70,386,306
3 Mo. Net Change: -2,442,496
# New Positions: 14
# Closed Positions: 13
# Increased Positions: 54
# Reduced Positions: 58
# Net Buyers: -4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.